Pasar al contenido principal

MODULACION DEL DOLOR POR LOS RECEPTORES SIGMA-1 PERIFERICOS

SAF2016-80540-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(+)-Methyl (1R,2S)-2-{[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: Stereochemistry and pharmacological gands: Stereochemistry and Pharmacological propertiesProperties

  • Amata, Emanuele
  • Rescifina, Antonio
  • Prezzavento, Orazio
  • Arena, Emanuela
  • Dichiara, Maria
  • Pittalà, Valeria
  • Montilla-García, Ángeles
  • Punzo, Francesco
  • Merino, Pedro
  • Cobos, Enrique J.
  • Marrazzo, Agostino
Methoxycarbonyl-1-phenyl-2-cyclopropylmethyl based derivatives cis-(+)-1a [cis-(+)-MR200], cis-(-)-1a [cis-(-)-MR201], and trans-(±)-1a [trans-(±)-MR204], have been identified as new potent sigma (σ) receptor ligands. In the present paper, novel enantiomerically pure analogues were synthesized and optimized for their σ receptor affinity and selectivity. Docking studies rationalized the results obtained in the radioligand binding assay. Absolute stereochemistry was unequivocally established by X-ray analysis of precursor trans-(+)-5a as camphorsulfonyl derivative 9. The most promising compound, trans-(+)-1d, showed remarkable selectivity over a panel of more than 15 receptors as well as good chemical and enzymatic stability in human plasma. An in vivo evaluation evidenced that trans-(+)-1d, in contrast to trans-(-)-1d, cis-(+)-1d, or cis-(-)-1d, which behave as σ1 antagonists, exhibited a σ1 agonist profile. These data clearly demonstrated that compound trans-(+)-1d, due to its σ1 agonist activity and favorable receptor selectivity and stability, provided an useful tool for the study of σ1 receptors., This work was supported by Research Funding for University (FIR) 2014 project code 108D20.This study was partially supported by the Spanish Ministry of Economy and Competitiveness (grant SAF2016-80540-R), the Junta de Andalucia (grant CTS109) and FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors

  • Ruiz-Cantero, M. Carmen
  • Cortés-Montero, Elsa
  • Jain, A.
  • Montilla-García, Ángeles
  • Bravo-Caparros, I.
  • Shim, J.
  • Sánchez-Blázquez, Pilar
  • Woolf, CJ.
  • Baeyens, José M.
  • Cobos, Enrique J.
Background and PurposePeripheral sensitization contributes to pathological pain. While prostaglandin E2 (PGE2) and nerve growth factor (NGF) sensitize peptidergic C-nociceptors (TRPV1+), glial cell line-derived neurotrophic factor (GDNF) sensitizes non-peptidergic C-neurons (IB4+). The sigma-1 receptor (sigma-1R) is a Ca2+-sensing chaperone known to modulate opoid analgesia. This receptor binds both to TRPV1 and the mu opioid receptor, although the functional repercussions of these physical interactions in peripheral sensitization are unknown.Experimental ApproachWe tested the effects of sigma-1 antagonism on PGE2-, NGF-, and GDNF-induced mechanical and heat hyperalgesia in mice. We used immunohistochemistry to determine the presence of endomorphin-2, an endogenous mu receptor agonist, on dorsal root ganglion (DRG) neurons. Recombinant proteins were used to study the interactions between sigma-1R, mu- receptor, and TRPV1. We used calcium imaging to study the effects of sigma-1 antagonism on PGE2-induced sensitization of TRPV1+ nociceptors.Key ResultsSigma1 antagonists reversed PGE2- and NGF-induced hyperalgesia but not GDNF-induced hyperalgesia. Endomorphin-2 was detected on TRPV1+ but not on IB4+ neurons. Peripheral opioid receptor antagonism by naloxone methiodide or administration of an anti-endomorphin-2 antibody to a sensitized paw reversed the antihyperalgesia induced by sigma-1 antagonists. Sigma-1 antagonism transfers sigma-1R from TRPV1 to mu receptors, suggesting that sigma-1R participate in TRPV1-mu receptor crosstalk. Moreover, sigma-1 antagonism reversed, in a naloxone-sensitive manner, PGE2-induced sensitization of DRG neurons to the calcium flux elicited by capsaicin, the prototypic TRPV1 agonist.Conclusion and ImplicationsSigma-1 antagonism harnesses endogenous opioids produced by TRPV1+ neurons to reduce hyperalgesia by increasing mu receptor activity., Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía, Grant/Award Number: CTS109; European Regional Development Fund; Secretaría de Estado de Investigación, Desarrollo e Innovación, Grant/Award Numbers: FPU 15/02356 (E Cortés-Montero), FPU16/03213 (MC Ruiz-Cantero), PID2019-108691RB-I00, SAF2016-80540-R; Universidad de Granada, Grant/Award Number: PPJIB2019.11; Universidad de Granada / CBUA; Harvard Medical School - Blavatnik Sensory Disorders Research Award, Peer reviewed